European Medicines Agency

Ljubljana – No major easing of anti-epidemic restrictions can be expected in the coming weeks, Prime Minister Janez Janša said on Friday, adding that the government would stick to the plan of easing adopted earlier this month, which means that schools and businesses might have to close again if the situation deteriorated.

The European Medicines Agency says no new side effects linked to the coronavirus vaccine made by BioNTech and Pfizer - and used in Greece right now - were identified in the regulator's first safety update on Covid-19 vaccines.

The European Medicines Agency is now recommending that a second dose of Pfizer's Covid-19 vaccine be given three weeks after the first, as many countries consider ways to stretch scarce supplies of shots.

According to previous data, the EU managed to administer about 8.9 million doses, or two doses per 100 inhabitants. The United States and Great Britain have so far vaccinated seven, that is to say, 10.5 inhabitants per 100, respectively, and Israel is currently at 43.

This morning, another shipment of Pfizer vaccines,14,040 doses - arrived in Sofia Airport. They will make up for the amount that didn't arrive last week. Another 2,300 doses of the vaccine are expected to come from the same company, again as a compensation for the delayed deliveries.

The reports of my European colleagues raise great concern - a huge number of infected, huge number of deaths, overburdened healthcare system, huge external debts and a slump in the GDP of the leading EU Member States, which is why after the health crisis is over there will inevitably be a very severe financial and economic crisis, Prime Minister Boyko Borissov said after the end of the European

Ljubljana – Prime Minister Janez Janša said he expected 70% of the Slovenian population could be vaccinated against coronavirus by the beginning of summer as he presented Tuesday fresh figures on planned deliveries of vaccines that indicate Slovenia should get significantly more jabs in the second quarter than previously thought.

Austria, Greece and Denmark will jointly pressure the European Medicines Agency to approve AstraZeneca's COVID-19 vaccine as quickly as possible, Austrian Chancellor Sebastian Kurz said on Monday, adding: "Every week counts."

US firm Johnson & Johnson is likely to apply for EU approval for its Covid-19 vaccine candidate in February, a top lawmaker said on Wednesday.

Clinical data of the vaccine, which Johnson & Johnson is developing through its subsidiary Janssen, have been assessed by the European Medicines Agency (EMA) since Dec. 1 under a rolling review to speed up possible approval.

Greece has received the first batch of coronavirus vaccines developed by Moderna Inc.

Coming on top of ongoing distribution of Pfizer-BioNTech shots, the country received the first 8,000 doses of the vaccine, approved for use by the European Medicines Agency (EMA) last week, and expects a total of 20,000 doses to be delivered by the end of January.